Zydus Lifesciences has been able to accomplish a pre-Approval Inspection PAI successfully without any observation by the US Food and Drug Administration (USFDA) at its SEZ II manufacturing facility in Ahmedabad.
Granules India Ltd. announced that the USFDA has issued an Establishment Inspection Report (EIR) for Granules Pharmaceuticals, Inc., a wholly-owned subsidiary of Granules India Ltd. in Chantilly, Virginia.
India pharmaceutical industry is going next-generation cell and gene therapy decisively, inspiring cancer treatment accessibility at a lower cost.
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, is stepping up its focus on India’s fast-growing healthcare sector, eyeing investments in single-specialty hospitals and contract drug manufacturing...
Mankind Pharma said it has secured a 'B' ESG rating from MSCI ESG Ratings and Research Private Limited in a key milestone that validates the company's journey toward better sustainability and governance standards...
Expressions of interest (EoI) have been invited by the Indian Council of Medical Research (ICMR) to firms, manufacturers and research organizations that have the capability to develop and produce monoclonal antibodies (mAbs) against Nipah virus...
In response to the ongoing ‘Nasha Mukti Bharat Abhiyan’ and under the clear directives of FDA Commissioner Manoj Kumar, the drug control administration (DCA) in Haryana conducted a significant and coordinated inspection operation in Sirsa district on
JB Chemicals and Pharmaceuticals, along with USV, are conducting a voluntary recall of antihistamine medications in the United States.
Pharmaceutical giant Sun Pharmaceutical Industries is anticipated to report consistent revenue growth, albeit with subdued profitability in its results for the September 2025 quarter (Q2FY26), impacted by increased costs associated with its US
The Subject Expert Committee (SEC) which is under the Central Drugs Standard Control Organization (CDSCO) has given the green signal to AstraZeneca India Pharma Limited’s application of Sodium Zirconium Cyclosilicate